30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mallon Mark

Insider profile

Performance

Overall performance
0.7

Performance over holding periods
0.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Mallon Mark's trades of Neogenomics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-12-06 2021-12-06 B Purchase
33,531 +1.0%
332.59
US$4,804,619
33,531 +1.0% 332.59 US$4,804,619
2021-03-02 2021-02-26 PlS Planned sale
77,896 -5.5%
460.53
US$2,083,385
77,896 -5.5% 460.53 US$2,083,385
2021-03-02 2021-02-26 PlS Planned sale
21,438 +22.4%
249.84
US$4,321,200
21,438 +22.4% 249.84 US$4,321,200
2020-05-13 2020-05-11 PlS Planned sale
23,206 -4.4%
10.35
US$240,182
23,206 -4.4% 10.35 US$240,182
2020-02-25 2020-02-24 PlS Planned sale
1 -0.0%
11.25
US$11
1 -0.0% 11.25 US$11
2020-02-25 2020-02-21 PlS Planned sale
7,983 -2.6%
11.63
US$92,842
7,983 -2.6% 11.63 US$92,842